Arcturus Therapeutics Holdings Inc (ARCT)
16.91
-0.16
(-0.94%)
USD |
NASDAQ |
Nov 22, 16:00
16.94
+0.03
(+0.18%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Price to Book Value: 1.749 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 1.749 |
| November 21, 2024 | 1.766 |
| November 20, 2024 | 1.673 |
| November 19, 2024 | 1.868 |
| November 18, 2024 | 1.683 |
| November 15, 2024 | 1.657 |
| November 14, 2024 | 1.897 |
| November 13, 2024 | 1.984 |
| November 12, 2024 | 2.025 |
| November 11, 2024 | 2.107 |
| November 08, 2024 | 2.03 |
| November 07, 2024 | 1.938 |
| November 06, 2024 | 1.896 |
| November 05, 2024 | 1.898 |
| November 04, 2024 | 1.843 |
| November 01, 2024 | 1.862 |
| October 31, 2024 | 1.834 |
| October 30, 2024 | 1.902 |
| October 29, 2024 | 1.978 |
| October 28, 2024 | 2.024 |
| October 25, 2024 | 1.960 |
| October 24, 2024 | 1.965 |
| October 23, 2024 | 2.068 |
| October 22, 2024 | 2.047 |
| October 21, 2024 | 2.160 |
| Date | Value |
|---|---|
| October 18, 2024 | 2.188 |
| October 17, 2024 | 2.131 |
| October 16, 2024 | 2.134 |
| October 15, 2024 | 2.169 |
| October 14, 2024 | 2.164 |
| October 11, 2024 | 2.220 |
| October 10, 2024 | 2.132 |
| October 09, 2024 | 2.264 |
| October 08, 2024 | 2.324 |
| October 07, 2024 | 2.469 |
| October 04, 2024 | 2.470 |
| October 03, 2024 | 2.561 |
| October 02, 2024 | 2.635 |
| October 01, 2024 | 2.612 |
| September 30, 2024 | 2.400 |
| September 27, 2024 | 2.304 |
| September 26, 2024 | 2.277 |
| September 25, 2024 | 2.229 |
| September 24, 2024 | 2.274 |
| September 23, 2024 | 2.212 |
| September 20, 2024 | 2.155 |
| September 19, 2024 | 2.198 |
| September 18, 2024 | 2.149 |
| September 17, 2024 | 2.197 |
| September 16, 2024 | 2.155 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.446
Minimum
Mar 22 2023
70.31
Maximum
May 22 2020
5.642
Average
3.042
Median
Price to Book Value Benchmarks
| Bioventus Inc | 5.146 |
| Fulcrum Therapeutics Inc | 0.6813 |
| Pfizer Inc | 1.575 |
| AIM ImmunoTech Inc | 4.596 |
| Protalix BioTherapeutics Inc | 3.836 |
Price to Book Value Related Metrics
| PS Ratio | 3.197 |
| Price | 16.91 |
| Earnings Yield | -13.13% |
| Market Cap | 458.05M |